Glucose Response of G-Pen (Glucagon Injection) in Pediatric T1D Patients

NCT03091673 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

31

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 1

Interventions

DRUG: Glucagon

Sponsor

Xeris Pharmaceuticals

Collaborators

[object Object]